Back

Long-term impact of residual inflammatory risk in acute myocardial infarction patients with low LDL Cholesterol levels

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Inflammation in chronic coronary syndromes Inflammation and Immunity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Chan Joon Kim

Uijeongbu St. Mary's Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Influenza vaccination and risk of cardiovascular events: a prespecified instrumental variable analysis of NUDGE-FLU-CHRONIC
Doctor D. Modin (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Assessing the cardiovascular toll of chronic inflammatory arthropathies: a case-control study on coronary artery disease severity
Mr A. Castrillo Capilla (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Awareness and perceptions on the role of systemic inflammation in atherosclerotic cardiovascular disease and chronic kidney disease: a national study among cardiologists and nephrologists in China
Associate Professor X. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of nutritional status on MACCE in CAD patients: the mediating role of inflammation
Doctor Q. Sun (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The ARAMIS trial - Allopurinol in patients with Refractory Angina to iMprove Ischemic Symptoms
Doctor R. Azevedo (Sao Luis, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammation in chronic coronary syndromes

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes according to residual cholesterol and inflammatory risk in patients undergoing PCI
thumbnail
Congress Session
Impact of lipid and adipose tissue changes in acute coronary syndromes
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources